Results 11 to 20 of about 94,755 (223)

Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia [PDF]

open access: yesClinical Pharmacology: Advances and Applications, 2022
Constantine E Kosmas,1,2 Maria D Bousvarou,3 Andreas Sourlas,3 Evangelia J Papakonstantinou,4 Edilberto Peña Genao,2 Rogers Echavarria Uceta,2 Eliscer Guzman1,2 1Division of Cardiology, Department of Medicine, Montefiore Medical Center, Bronx, NY, USA ...
Kosmas CE   +6 more
doaj   +5 more sources

Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia. [PDF]

open access: yesInt J Mol Sci, 2021
Dyslipidemia is characterized by increasing plasma levels of low-density lipoprotein-cholesterol (LDL-C), triglycerides (TGs) and TG-rich lipoproteins (TGRLs) and is a major risk factor for the development of atherosclerotic cardiovascular disorders (ASCVDs).
Chen PY   +5 more
europepmc   +6 more sources

Angiopoietin-like protein 3: a novel potential biomarker for nephrotic syndrome in children [PDF]

open access: yesFrontiers in Pediatrics, 2023
BackgroundAngiopoietin-like 3 (ANGPTL3) is a secretory glycoprotein. It has been demonstrated that ANGPTL3 level was upregulated in minimal change nephrotic syndrome (MCNS) kidney tissues.
Fujie Wen   +11 more
doaj   +4 more sources

Angiopoietin-like protein 3 markedly enhanced in the hyperlipidemia related proteinuria [PDF]

open access: yesLipids in Health and Disease, 2019
Background Angiopoietin-like protein 3(ANGPTL3) is well acknowledged as a key regulator of lipid metabolism. Now, there have not been enough data to explain the mechanism of hyperlipidemia related proteinuria.
Xia Gao   +6 more
doaj   +5 more sources

Serum Angiopoietin-like Protein 3 Levels Are Associated with Endothelial Function in Patients with Maintenance Hemodialysis [PDF]

open access: yesLife, 2023
Angiopoietin-like protein 3 (ANGPTL3) plays an important role in lipid and lipoprotein trafficking and metabolism and is positively correlated with cardiovascular disease.
Tzu-Chiang Wu   +4 more
doaj   +3 more sources

Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism1[S] [PDF]

open access: yesJournal of Lipid Research, 2016
The consequences of angiopoietin-like protein 3 (ANGPTL3) deficiency on postprandial lipid and lipoprotein metabolism has not been investigated in humans.
Ilenia Minicocci   +14 more
doaj   +6 more sources

Positive correlation of the serum angiopoietin-like protein 3 levels with the aortic augmentation index in patients with coronary artery disease [PDF]

open access: yesTherapeutics and Clinical Risk Management, 2018
Yu-Shan Fu,1,* Ji-Hung Wang,1,2,* Chung-Jen Lee,3 Bang-Gee Hsu1,4 1School of Medicine, Tzu Chi University, Hualien, 2Division of Cardiology, Buddhist Tzu Chi General Hospital, Hualien, 3Department of Nursing, Tzu Chi University of Science and Technology,
Fu YS, Wang JH, Lee CJ, Hsu BG
doaj   +3 more sources

Regulation of the angiopoietin-like protein 3 gene by LXR [PDF]

open access: yesJournal of Lipid Research, 2003
Angiopoietins are members of the vascular endothelial growth factor family. One family member, angiopoietin-like protein 3 (Angpt1111111175), was recently shown to be predominantly expressed in the liver and to play an important role in regulating lipid ...
Rebecca Kaplan   +6 more
doaj   +3 more sources

Positive correlation of serum angiopoietin-like protein 3 levels with metabolic syndrome in patients with coronary artery disease [PDF]

open access: yesTzu Chi Medical Journal, 2022
Objectives: Angiopoietin-like protein 3 (ANGPTL3) regulates triglyceride metabolism by reversibly inhibiting the lipoprotein lipase activity. Metabolic syndrome (MetS) is an independent risk factor for further cardiovascular disease. This study evaluated
Sy-Harn Lian   +3 more
doaj   +2 more sources

Antisense oligonucleotide–mediated inhibition of angiopoietin-like protein 3 increases reverse cholesterol transport in mice [PDF]

open access: yesJournal of Lipid Research, 2021
Supported by an abundance of experimental and genetic evidence, angiopoietin-like protein 3 (ANGPTL3) has emerged as a promising therapeutic target for cardiovascular disease. ANGPTL3 is primarily produced by the liver and is a potent modulator of plasma
Thomas A. Bell, III   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy